What is Gelesis Holdings, Inc.'s annual revenue?

Gelesis Holdings, Inc. (GLSHQ) reported annual revenue of $26.0M in its most recent fiscal year.

What is Gelesis Holdings, Inc.'s net profit?

Gelesis Holdings, Inc. (GLSHQ) reported net profit of $-57.0M in its most recent fiscal year.

What is GLSHQ EV/EBITDA?

Gelesis Holdings, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.55.

OTC · Financial Statements

Gelesis Holdings, Inc. (GLSHQ) Financial Statements

$0.00 OTC: GLSHQ Market Cap $7334

Gelesis Holdings, Inc. most recently reported annual revenue of $26.0M, net profit of $-57.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2020	2021	2022
Revenue	$0	$11.0M	$26.0M
Operating Profit	$0	$-85.0M	$-122.0M
Net Profit	$-15.0M	$-94.0M	$-57.0M
EPS	$-0.44	$-16.41	$-1.35
Op Margin	—	-759.7%	-472.7%

Balance Sheet (USD)

Metric	2020	2021	2022
Total Assets	$277.0M	$146.0M	$103.0M
Total Liabilities	$41.0M	$146.0M	$116.0M
Cash	$0	$28.0M	$7.0M
Borrowings	$0	$66.0M	$62.0M

Cash Flow (USD)

Metric	2020	2021	2022
Operating Cash Flow	$-1.0M	$-55.0M	$-78.0M
Investing Cash Flow	$-276.0M	$8.0M	$-18.0M
Financing Cash Flow	$277.0M	$0	$71.0M
Net Cash Flow	$0	$-20.0M	$-21.0M
Free Cash Flow	$-1.0M	$-75.0M	$-87.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.01
EV / EBITDA	-0.55
FCF Yield	-746.72%
Quick Ratio	0.33
Interest Coverage	-122.91
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

GLSHQ Overview GLSHQ Dividend Run Stock Screener